Halozyme Therapeutics Incorporate.../ US40637H1095 /
| 8/2/2024 10:00:00 PM | Chg. -0.9600 | Volume | Bid1:15:34 AM | Ask1:15:34 AM | High | Low |
|---|---|---|---|---|---|---|
| 54.0900USD | -1.74% | 1.18 mill. Turnover: 46.78 mill. |
53.5000Bid Size: 100 | 58.0000Ask Size: 100 | 55.0100 | 52.7500 |
Business description
-
Management board & Supervisory board
| CEO |
|---|
| Helen Torley |
| Management board |
| Nicole LaBrosse, Mark Snyder, Michael J. LaBarre, Chris Wahl, Cortney Caudill, Tram Bui, Gary Grote, Amy Fox, Steve Knowles, Christopher Bryant, Kristin Schwartzbauer |
| Supervisory board |
| Jeffrey W. Henderson, Jean-Pierre Bizzari, Barbara Duncan, Matthew L. Posard, Connie L. Matsui, Moni Miyashita, Bernadette Connaughton, Helen Torley |
